ABSTRACT: Peroxisome proliferator-activated receptor γ2 (PPARγ) is a nuclear transcription factor that regulates adipocyte differentiation and lipogenic genes during adipogenesis. The activity of rodent PPARγ is regulated by phosphorylation of serine 112. The current experiment was designed to study the ability of porcine PPARγ to stimulate transdifferentiation of myoblasts to adipocytes by overexpressing wild-type PPARγ or mutated PPARγ (serine 112 was mutated to alanine) in mouse myoblast cells. The expression of adipogenic marker genes (adipocyte fatty acid binding protein, lipoprotein lipase, and glycerol-3 phosphate dehydrogenase) in cells stably expressing mutated porcine PPARγ was greater than in cells with wild-type PPARγ, indicating that the mutated PPARγ has greater adipogenic
INTRODUCTION
The peroxisome proliferator-activated receptor γ2 (PPARγ) is a critical transcription factor in the regulation of adipogenesis. Ectopic expression of rodent PPARγ in fibroblasts stimulates adipocyte development (Tontonoz et al., 1994) . In addition, expression of rodent PPARγ and the CCAAT/enhancer-binding protein α (C/EBPα) in myoblasts activates an adipogenic program in this cell line . The regulation of PPARγ activity is posttranslationally modified. Phosphorylation of rodent PPARγ serine 112 by mitogen-activated protein (MAP) kinase decreases the ability of PPARγ to regulate adipogenic genes and decreases differentiation (Hu et al., 1996) . In NIH 3T3 cells, replacement of rodent PPARγ serine 112 with alanine promotes the function of PPARγ during adipogenesis and enhances the ligand sensitivity through 1 This work was supported by National Science Council in Taiwan. 2 Visiting professor at National Taiwan University.
3 capability than the wild-type PPARγ. Under treatment with a ligand, both wild-type and mutant porcine PPARγ-expressing C2C12 myoblasts differentiated into adipocytes in 10 d. The expression of myogenic marker genes (myogenin, myogenic regulatory factor-4) was suppressed in cells transfected with the mutated PPARγ or wild-type PPARγ. Moreover, wild-type and mutant PPARγ were able to inhibit myogenesis without addition of a ligand. Our results suggest that porcine wild-type PPARγ and mutated PPARγ can both convert myoblast cells into adipocytes, and also that the ability to transdifferentiate was greater in cells containing the mutated PPARγ than in cells containing the wild-type PPARγ. Therefore, the existence of serine 112 in PPARγ may have a role in regulating adipocyte differentiation. prevention of MAP kinase phosphorylation (Hu et al., 1996) .
Thiazolidinediones (TZD), compounds used to treat type 2 diabetes, are ligands for PPARγ (Kletzein et al., 1992) . The TZD act as adipogenic agents in porcine preadipocytes, suggesting they are ligands for porcine PPARγ (Tchoukalova et al., 2000) . Although the expression of PPARγ is positively associated with porcine adipocyte differentiation (Ding et al., 1999) , there is no direct evidence to demonstrate the function of porcine PPARγ on adipocyte differentiation. Intramuscular fat is not abundant in porcine muscle. Thus, it is of interest to increase the number of intramuscular adipocytes. In this study, we transfected the myogenic C2C12 myoblast cell line with wild-type or mutated porcine PPARγ (ser 112→ala). Upon addition of a PPARγ ligand, transfected cells with wild-type PPARγ or mutated PPARγ were transdifferentiated from a myogenic to an adipogenic type.
MATERIALS AND METHODS

Full Length cDNA Cloning and Gene Construction
The animal protocol was approved by the Animal Care and Use Committee of the National Taiwan Uni- versity. Two 2-mo-old crossbred pigs were killed by electrocution combined with exsanguination for gene cloning and gene expression studies (Liu et al., 2005) . Longissimus muscle and s.c. adipose tissue were obtained, and RNA was extracted with guanidinium-phenol-chloroform (Chomczynski and Sacchi, 1987) using modifications by Hsu and Ding (2003) . Total RNA was reverse transcribed using a kit, SuperScript II FirstStrand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA). First strand cDNA from pig adipose tissue was used for cloning PPARγ2 (Accession No. AF103946). The point-mutated PPARγ (ser 112→ala), which resulted in a nonfunctional phosphorylation site, was created by primer design. The PCR products were cloned into a mammalian expression vector with a CMV promoter (pIRES-EGFP, Clontech, Mountain View, CA) to drive the expression of wild-type PPARγ or mutated PPARγ. Sequences of these recombinant molecules were determined and confirmed.
Establishment of Cell Lines Stably Expressing Pig PPARγ
The C2C12 myoblasts (CRL-1772, ATCC, Manassas, VA) were cultured in Dulbecco's modified Eagle medium (DMEM) with 10% fetal bovine serum (FBS) at 37°C in an atmosphere of 5% CO 2 in air. After confluence, C2C12 myoblast cells differentiated into mature myotubes when the serum concentration was lowered by replacing the 10% FBS with 2% horse serum.
The empty mammalian expression vector (CV) or vector containing wild-type PPARγ or mutated PPARγ was transfected into C2C12 myoblasts by lipofection (Fugene 6, Roche Applied Science, Indianapolis, IN). Cell lines stably expressing CV or PPARγ were established by antibiotic selection using G418. In this system, antibiotic resistance is an indication of successful integration of foreign genes into the genome of the cells. After transfection with individual plasmids, cells were maintained in nonselective medium for 2 d, after which the nonselective medium was replaced with selective medium containing the antibiotic. The selection Figure 1 . Analysis of exogenous wild-type porcine peroxisome proliferator-activated receptor γ2 (PPARγ) and mutated porcine PPARγ in C2C12 myoblasts. The C2C12 control cells (C), C2C12 cells expressing wild-type PPARγ (WT), and C2C12 cells expressing mutated PPARγ (MU) were cultured in Dulbecco's modified Eagle medium+10% fetal bovine serum until confluence was reached. Total RNA (20 g) was analyzed for porcine PPARγ and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by northern blot. Tissue total RNA from pig adipose tissue (F) and muscle (M) was used for positive and negative comparison. Two crossbred pigs were used for the study. The GAPDH was an indicator of equivalent RNA loading. Expression of adipogenic and myogenic marker genes. After confluence, normal C2C12 myocytes (C), C2C12 expressing empty vector (CV1 and CV2), C2C12 expressing wild-type porcine peroxisome proliferator-activated receptor γ2 (PPARγ; WT), and C2C12 expressing mutated porcine PPARγ (MU) were cultured for 10 d. The expression of adipocyte-specific genes [lipoprotein lipase (LPL) and adipocyte fatty acid-binding protein (aP2)] and myogenic genes [myoblast determination protein-1 (MyoD) and myogenin] was determined and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The bars indicate the means ± SE from cells for 3 independent replicates (n = 3). ND = not detected. Means without a common letter differ, P < 0.05. Rosi = 1 M of rosiglitazone treatment.
was for at least 1 mo. Dead cells were eliminated through frequent replacement of the selective medium, until distinct colonies could be visualized under the selective-medium environment. Individual colonies were isolated to culture cells for further propagation.
Induction of Myocyte Transdifferentiation
After the cell lines were established, the cells were cultured without selection medium and allowed to propagate to 80% confluence in DMEM with 10% FBS. Confluent cells were then cultured in adipogenic differentiation medium [DMEM containing 10% FBS, 1 M dexamethasone, and 5 g/mL insulin with or without 1 M rosiglitazone, a PPARγ ligand]. For myogenic differentiation, cells were cultured in DMEM plus 2% horse serum, with or without 1 M PPARγ ligand.
Cells were cultured in myogenic or adipogenic medium for 10 d, with a medium change every 2 d. The adipogenic and myogenic media ± rosiglitazone, were used to assess the capacity of C2C12 myoblasts containing wild-type or mutated PPARγ to modify adipogenesis and myogenesis. Each experiment was repeated 3 times.
After 10 d of culture, cells on the plates were stained with Oil Red O to measure the degree of adipocyte differentiation (Ramirez-Zacarias et al., 1992) . Cellular RNA was extracted to determine the mRNA concentrations for several genes whose expression increases during adipocyte differentiation: PPARγ, lipoprotein lipase (LPL; an early marker), adipocyte fatty acidbinding protein (aP2; a late marker), and glycerol-3 phosphate dehydrogenase (GPDH; a marker for triacylglycerol synthesis activity). The mRNA for genes representating myoblast differentiation were also measured: myoblast determination protein-1 (MyoD; an early marker), myogenic factor-5 (Myf5; an early marker), myogenin (a late marker), and myogenic regulatory factor-4 (MRF4; a late marker).
Extraction of RNA
Total RNA was extracted for northern analysis. The quality of the RNA was monitored by examination of the 18S and 28S ribosomal RNA bands after electrophoresis. The RNA was quantified by spectrophotometry at 260 nm and stored at −70°C.
Northern Analysis
Total RNA (20 g of each sample) was electrophoresed and transferred to nylon membranes. The probes for the genes measured were generated by PCR using the primer pairs listed in Table 1 . The membrane was prehybridized at 42°C in UltraHyb (Ambion, Austin, TX) for 1 h, and then the denatured cDNA probe (95°C for 5 min) was added at a concentration of 1 pM and allowed to hybridize with the targeted gene transcripts overnight at 42°C. Hybridization was quantified by phosphor-image analysis as previously described (Hsu Expression of adipogenic marker genes. After confluence, normal C2C12 myocytes (C), C2C12 expressing wild-type porcine peroxisome proliferator-activated receptor γ2 (PPARγ; WT), and C2C12 expressing mutated porcine PPARγ (MU) were cultured for 10 d. The expression of adipocyte-specific genes [PPARγ, lipoprotein lipase (LPL), adipocyte fatty acid-binding protein (aP2), and glycerol-3 phosphate dehydrogenase (GPDH)] was determined and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The bars indicate the means ± SE from cells for 3 independent replicates (n = 3). ND = not detected. Means without a common letter differ, P < 0.05. Rosi = 1 M of rosiglitazone treatment. et al., 2004; Wang et al., 2006) . The densitometric value for an individual transcript in a sample lane was normalized to the densitometric value for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in the same lane.
Statistical Analysis
The treatment effects were analyzed using an AN-OVA procedure to determine the main effects of the form of PPARγ and presence or absence of a ligand. Duncan's new multiple range test was used to evaluate differences among means (SAS Inst. Inc., Cary, NC). A significant difference indicates that P value is not greater than 0.05.
RESULTS
Ectopic Expression of Wild-Type PPARγ and Mutated PPARγ in C2C12 Myoblasts
Expression of pig PPARγ in adipose tissue was robust, whereas expression in muscle was weak ( Figure  1) . No PPARγ was detected in the RNA from untransfected C2C12 myoblasts (Figure 1) . However, C2C12 myoblasts transfected with wild-type porcine PPARγ or mutated porcine PPARγ expressed a high level of PPARγ mRNA (Figure 1 ).
Wild-Type PPARγ and Mutated PPARγ Trigger Transdifferentiation in Adipogenic Medium
The stably transformed porcine PPARγ or mutated PPARγ increased the expression of aP2 and LPL, 2 PPARγ targeting genes (Figure 2) . Two empty vector containing C2C12 clones (CV1 and CV2) expressed aP2, LPL, MyoD, and myogenin (myogenic markers) in the same manner as in the normal C2C12 cells, indicating that the insertion of the vector does not have an effect on the expression of adipogenic and myogenic genes in these cells. The addition of TZD did not affect the expression of adipogenic or myogenic genes in the CV1 and CV2 (Figure 2) . Normal C2C12 cells differentiate to multinucleated myotubes in adipogenic medium (Figure 3, panel A) . The presence or absence of rosiglitazone in adipogenic medium had no effects on myogenesis (Figure 3, panel A vs. D) . Rosiglitazone at 1 M did not trigger myoblast transdifferentiation into adipocytes. In contrast, myoblasts expressing native PPARγ or mutated PPARγ were maintained but did not progress to myotubes (Figure 3 , panels B and C). This observation demonstrated that porcine PPARγ was able to block the myogenic program without exogenous ligand activation. However, after addition of rosiglitazone to the adipogenic differentiation medium for 10 d, lipid droplets were visualized in myoblasts expressing wild-type PPARγ and mutated PPARγ (Figure 3 , panels E and F). To determine the degree of accumulation of intracellular triacylglycerol, cells were stained with Oil-Red-O and photographed on d 10 (Figure 3 , panels G to L). After Oil-Red-O staining, myoblasts expressing wild-type PPARγ or mutated PPARγ displayed a low degree of triacylglycerol accumulation when no ligand was added to the adipogenic medium (Figure 3 , panels H and I). However, after addition of the ligand to adipogenic medium, high levels of triacylglycerol were observed in wild-type PPARγ and mutated PPARγ C2C12 myoblasts (Figure 3 , panels K and L).
Normal C2C12 myoblasts in adipogenic medium had a low level of PPARγ mRNA expression (Figure 4 , panel A). The PPARγ mRNA expression may result from the medium insulin and dexamethasone, but the expression was not great enough to trigger the myoblast transdifferentiation even in the presence of rosiglitazone. The PPARγ mRNA expression in myoblasts containing wild-type PPARγ or mutated PPARγ was the same and at a high level (Figure 4, panel A) . These levels were enough to cause the expression of downstream genes for adipogenesis, especially in the presence of the PPARγ ligand, rosiglitazone. Lipoprotein lipase could not be detected in normal C2C12 ( Figure  4, panel B) . However, high levels of LPL expression were obtained in cells ectopically expressing PPARγ under rosiglitazone stimulation (Figure 4, panel B) . Similar results (Figure 4 , panels C and D) were obtained for other PPARγ activated genes, aP2 and GPDH. Further experiments demonstrated that the effectiveness of increasing the expression of PPARγ targeting genes (aP2 and LPL) was greater by mutated Figure 6 . Expression of myogenic marker genes. After confluence, normal C2C12 myoblasts (C), C2C12 expressing wild-type porcine peroxisome proliferator-activated receptor γ2 (PPARγ; WT), and C2C12 expressing mutated porcine PPARγ (MU) were grown for 10 d in adipogenic medium. The expression of myogenic genes [myoblast determination protein-1 (MyoD), myogenic factor-5 (Myf5), Myogenin, and myogenic regulatory factor-4 (MRF4)] was determined and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The bars indicate the means ± SE for cells from 3 independent replicates (n = 3). ND = not detected.
a-c Means without a common letter differ, P < 0.05. Rosi = 1 M of rosiglitazone treatment.
PPARγ compared with the wild-type PPARγ under several concentrations of its ligand ( Figure 5) . These results demonstrated that exogenous porcine PPARγ could cause expression of adipogensis-related genes to trigger the adipogenic program in C2C12 myoblasts.
Myogenic gene, MyoD, was expressed in all cell types at an equivalent level in the presence or absence of ligand ( Figure 6, panel A) . However, another early expressed myogenic marker, Myf5, was expressed at a greater level in cells transfected with wild-type PPARγ or mutated PPARγ compared with control cells; addition of rosiglitazone had no effect ( Figure 6, panel  B) . The mRNA for myogenin and MRF4, genes representing later stages of myoblast differentiation, were expressed at a lower level in C2C12 cells expressing the wild-type PPARγ or the mutated PPARγ compared with normal C2C12 (Figure 6, panels C and D) . Our experiments demonstrated that PPARγ could downregulate myogenic differentiation genes and inhibit myogenesis in adipogenic medium whether rosiglitazone was present or not.
Wild-Type PPARγ and Mutated PPARγ Suppressed Myogenesis
Normal C2C12 myoblasts differentiate very well to form myotubes under a 2% horse serum treatment (Figure 7, panel A) . Addition of the PPARγ-ligand to the myogenic medium had no effect on myogenic differention (Figure 7, panel D) . In contrast, cells expressing wild-type PPARγ or mutated PPARγ maintained an undifferentiated state, and myotubes were rarely visualized in myogenic medium (Figure 7 , panels B and C). Addition of rosiglitazone to myogenic medium trig- gered a small degree of readily visualized lipid-droplet formation in both kinds of genetically modified cells (Figure 7 , panels E and F).
The expression of PPARγ was greater in C2C12 cells expressing wild-type or mutated PPARγ compared with normal C2C12 (Figure 8, panel A) . The adipogenic gene LPL was not expressed in normal myoblasts but was observed in myoblasts transfected with PPARγ ( Figure 8, panel B) . Addition of a PPARγ-ligand, rosiglitazone further enhanced adipogenesis, as indicated by an increase number of lipid-containing cells ( Figure  8 , panels E and F) and increased LPL mRNA ( Figure  8, panel B) . The C2C12 cells expressing wild-type or mutated PPARγ both expressed aP2 and GPDH when the PPARγ-ligand was added (Figure 8 , panels C and D). Thus, increased adipogenic gene expression was detected before extensive lipid deposition. The cells expressing the mutated PPARγ had increased levels of mRNA for adipogenic genes compared with cells expressing the wild-type PPARγ (Figure 8 , panels B, C, and D).
The expression of MyoD was the same in normal and genetically modified C2C12 cells, maintained in myogenic medium (Figure 9, panel A) . Another myogenesis early expressed gene, Myf5, was more highly expressed in both types of genetically modified C2C12 myoblasts than in normal C2C12 (Figure 9, panel B) . Expression of the myogenic terminal differentiation genes, myogenin and MRF4, was decreased by the presence of PPARγ (Figure 9 , panels C and D). Addition of the PPARγ-ligand did not further decrease expression of these genes.
DISCUSSION
Preadipocyte and myoblast lineages are derived from the same multipotent mesodermal progenitor (Grigoriadis et al., 1988) . After determination, preadipocytes and myoblasts undergo terminal differentiation and develop into functional cells. Differentiation of preadipocytes into adipocytes is regulated by several transcription factors, including PPARγ, C/EBPα, and sterol regulatory element binding protein-1c (SREBP1c or ADD1). During rodent adipogenesis, PPARγ is an early expressed transcription factor that stimulates the process of adipocyte differentiation in vitro and in vivo (Rosen et al., 1999) . Several adipogenesis-related genes are modulated by binding the ligand activated PPARγ to their PPARγ-response elements. For example, aP2 (Tontonoz et al., 1994) and phosphoenolpyruvate carboxykinase are regulated by PPARγ. Therefore, the primary transcription factor to stimulate rodent adipogenesis is PPARγ (Rosen et al., 1999) .
The differentiation of myoblasts and preadipocytes involves different transcription factor programs. In myogenesis, this process is regulated by a family of basic helix-loop-helix transcription factors, including MyoD, Myf5, myogenin, and MRF4. The MyoD and Myf5 are expressed at early stages and participate in myoblast determination, whereas myogenin and MRF4 are expressed at later stages and promote myotube formation in terminal differentiation (Weintraub et al., 1989; Emerson, 1993) . In recent years, mouse C2C12 and G8 myoblast cell lines have been used to Figure 8 . Expression of adipogenic marker genes in cells maintained in myogenic medium. Normal C2C12 myoblasts (C), C2C12 expressing wild-type porcine peroxisome proliferator-activated receptor γ2 (PPARγ; WT), and C2C12 expressing mutated porcine PPARγ (MU) were grown in myogenic medium ± 1 M rosiglitazone to d 10 postconfluence. The expression of adipocyte-specific genes [PPARγ, lipoprotein lipase (LPL), adipocyte fatty acid-binding protein (aP2), and glycerol-3 phosphate dehydrogenase (GPDH)] was determined and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The bars indicate the means ± SE for cells from 3 independent replicates (n = 3). ND = not detected. Means without a common letter differ, P < 0.05. Rosi = 1 M of rosiglitazone treatment. study the myogenic program. In addition to myogenesis, C2C12 myoblasts can differentiate into osteoblasts and adipocytes under appropriate culture conditions (Katagiri et al., 1994; Teboul et al., 1995; Nishimura et al., 1998) . Furthermore, ectopic expression of rodent PPAR γ and C/EBPα in G8 myoblasts induces myoblast conversion to adipocytes .
In rodents, the PPARγ serine 112 can be phosphorylated by MAP kinase during preadipocyte proliferation, and the phosphorylated PPARγ has reduced transcriptional regulatory activity (Hu et al., 1996; Shao et al., 1998 ). In the current study, the mutation of serine 112 in the porcine PPARγ seems to enhance the ability of PPARγ to regulate transcription of its targeting genes. However, a lack of phosphorylation information for the porcine PPARγ limits the ability to speculate the precise mechanism. Regardless of the precise mechanism, the mutated PPARγ has greater ability to promote adipogenesis in our C2C12 myoblasts than does the wild-type PPARγ. The results also support a model in which decreased phosphorylation of mutated PPARγ enhances transcriptional activity to drive adipogenesis.
The TZD enhance the sensitivity of tissues to insulin and are widely used to treat type-2 diabetes. Preadipocytes treated with TZD have increased expression of adipogenesis-related genes and differentiation (Kletzien et al., 1992) . It has been suggested that 5 M rosiglitazone activates adipogenic genes in mouse C2C12 myoblasts to trigger the conversion to adipocytes (Teboul et al., 1995) , although the rat L6 myoblast cell line did not trandifferentiate into adipocytes in the presence of TZD (Hammarstedt and Smith, 2003) . In our studies, addition of 1 M rosiglitazone to C2C12 myoblasts without the transfected PPARγ had no effect on transdifferentiation in adipogenic or Figure 9 . Expression of myogenic marker genes. Normal C2C12 myoblasts (C), C2C12 expressing wild-type porcine peroxisome proliferator-activated receptor γ2 (PPARγ; WT), and C2C12 expressing mutated porcine PPARγ (MU) were cultured for 10 d postconfluence in myogenic medium as indicated in Figure 7 . The expression of myocytespecific genes [myoblast determination protein-1 (MyoD), myogenic factor-5 (Myf5), Myogenin, and myogenic regulatory factor-4 (MRF4)] was determined and normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The bars indicate means ± SE for cells from 3 independent replicates (n = 3). Means without a common letter differ, P < 0.05. Rosi = 1 M of rosiglitazone treatment.
myogenic medium, suggesting that 1 M rosiglitazone was not enough to trigger the adipogenic program of myoblasts without the expression of exogenous PPARγ.
Expression of PPARγ and C/EBPα in G8 myoblasts causes transdifferentiation into adipocytes . In addition, C2C12 myoblasts transfected with PPARδ had increased endogenous PPARγ and conversion to adipocytes under TZD stimulation (Holst et al., 2003) . These results imply that ectopic expression of PPARγ with its ligand is able to enhance myocyte transdifferentiation to adipocytes. In the current studies, the addition of rosiglitazone to cells expressing porcine PPARγ increased the expression of adipogenic genes, i.e., LPL, aP2, and GPDH. In adipogenic medium, the mutated PPARγ had an increased capacity to enhance adipogenesis compared with the wild-type PPARγ only in the presence of the ligand. The strength of the adipogenic outcome in cells transfected with either PPARγ is indicated by the presence of a few lipid containing cells and increased LPL mRNA even when the myoblasts were cultured in myogenic medium.
The terminal myogenic differentiation genes, myogenin and MRF4, were reduced in cells containing either PPARγ type. During myogenesis, the MyoD expression is present at a steady state level, whereas the expression of Myf5 increased and peaked at d 4 then reduced until d 10 (Dedieu et al., 2002) . We observed the same expression of MyoD in all cells. However, the reason for the increased Myf5 expression in genetically modified cells compared with nontransfected myoblasts is unclear.
Taken together, porcine PPARγ was able to trigger myoblasts transdifferentiation into adipocytes in the presence of a PPARγ-ligand. The current finding is consistent with the hypothesis that decreased phosphorylation of mutated PPARγ has enhanced activity on stimulating adipocyte differentiation. Treatment with a PPARγ-ligand enhanced the adipogenic effect. Future targeting of the wild-type or mutated PPARγ to myoblasts in vivo may provide a mechanism to enhance marbling in pigs.
